Documentos relacionados

1. Contribution of VEGF-B-Induced Endocardial Endothelial Cell Lineage in Physiological Versus Pathological Cardiac Hypertrophy.
2. Porcupine inhibitor CGX1321 alleviates heart failure with preserved ejection fraction in mice by blocking WNT signaling.
3. Distinct roles of resident and nonresident macrophages in nonischemic cardiomyopathy.
4. Bicyclol Attenuates Obesity-Induced Cardiomyopathy via Inhibiting NF-κB and MAPK Signaling Pathways.
5. Proteomic profiling of sudden cardiac death with acquired cardiac hypertrophy.
6. Syringic acid mitigates isoproterenol-induced cardiac hypertrophy and fibrosis by downregulating Ereg.
7. cAMP induces hypertrophy and alters DNA methylation in HL-1 cardiomyocytes.
8. Effect of inflammation on cytochrome P450-mediated arachidonic acid metabolism and the consequences on cardiac hypertrophy.
9. Inhibition of MyD88 by LM8 Attenuates Obesity-Induced Cardiac Injury.
10. Paediatric dilated cardiomyopathy with and without endocardial fibroelastosis - a pathological analysis of 89 explants.